Policies to address disparities in clinical trials: The EDICT project
Policies to address disparities in clinical trials: The EDICT project
复制标题
DOI：
10.1080/08858190903400500
复制
发表时间：
2009-06-01
影响因子：
1.6
通讯作者：
Weinberg, Armin D.
中科院分区：
文献类型：
--
作者：
Spiker, Cynthia A.;Weinberg, Armin D.
临床试验是发现新的救命药物和开发更好的疾病预防，诊断和治疗方法的关键资源。当今大多数最有效的预防和治疗方法都是基于以前的临床试验结果。然而，许多群体在临床试验中的代表性不足，包括种族/少数民族、低收入者、老年人、妇女、残疾人、无保险者和生活在农村地区的人。不幸的是，这些人口还承受着不成比例的疾病负担。文献1
BACKGROUNDClinical trials are a critical resource for the discovery of new life-saving drugs and for developing better prevention, diagnostic, and treatment methods for disease. The majority of today's most effective prevention and treatment modalities are based upon previous clinical trials results. However, many groups are underrepresented in clinical trials, including racial/ethnic minorities, those with low income, the elderly, women, the disabled, the uninsured, and those who live in rural areas. Unfortunately, these populations also bear a disproportionate burden of disease. Citation 1